More than 60 patients groups yesterday urged Congress to protect the 340B drug savings program. “We stand together to oppose any efforts to diminish the 340B program’s proven ability to help serve vulnerable patients and communities,” wrote the groups. “340B is vital to the health care safety net as it enables trusted community providers to fulfill their missions. In many communities – particularly low-income rural and urban areas – safety net providers are the sole pathways to affordable health care.”

Related News Articles

Headline
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District…
Chairperson's File
Public
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
Chairperson's File
Public
In last month’s Chair File, we talked about some of the key priorities the AHA has for the remainder of 2025, one of which is protecting the 340B Drug Pricing…
Headline
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model…
Headline
The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing discussing the 340B Drug Pricing Program and its growth and impacts on…
Headline
The U.S. District Court for the District of Rhode Island Sept. 30 denied motions from AbbVie and Novartis seeking a preliminary injunction against the state’s…